Advertisement

Table of Contents

August 01, 1995; Volume 48,Issue 2

You have access
Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C.
G Pei, B L Kieffer, R J Lefkowitz and N J Freedman

Molecular Pharmacology August 1995, 48 (2) 173-177;
You have access
Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
R J Evans, C Lewis, G Buell, S Valera, R A North and A Surprenant

Molecular Pharmacology August 1995, 48 (2) 178-183;
You have access
Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
J Garthwaite, E Southam, C L Boulton, E B Nielsen, K Schmidt and B Mayer

Molecular Pharmacology August 1995, 48 (2) 184-188;
You have access
Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells.
T Tang, J G Kiang, T E Côté and B M Cox

Molecular Pharmacology August 1995, 48 (2) 189-193;
You have access
alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
D S Johnson, J Martinez, A B Elgoyhen, S F Heinemann and J M McIntosh

Molecular Pharmacology August 1995, 48 (2) 194-199;
You have access
Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization.
R S Westphal, J R Backstrom and E Sanders-Bush

Molecular Pharmacology August 1995, 48 (2) 200-205;
You have access
Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition.
K Hosoda, L R Fitzgerald, V A Vaidya, G K Feussner, P H Fishman and R S Duman

Molecular Pharmacology August 1995, 48 (2) 206-211;
You have access
Hormonal and cell density regulation of hepatic gamma-glutamylcysteine synthetase gene expression.
J Cai, W M Sun and S C Lu

Molecular Pharmacology August 1995, 48 (2) 212-218;
You have access
Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes.
S Shafqat, M Velaz-Faircloth, V A Henzi, K D Whitney, T L Yang-Feng, M F Seldin and R T Fremeau

Molecular Pharmacology August 1995, 48 (2) 219-229;
You have access
5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
M N Garnovskaya, C G Nebigil, J M Arthur, R F Spurney and J R Raymond

Molecular Pharmacology August 1995, 48 (2) 230-237;
You have access
Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
J R Spitzner, I K Chung, T D Gootz, P R McGuirk and M T Muller

Molecular Pharmacology August 1995, 48 (2) 238-249;
You have access
KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
K Shibata, R Foglar, K Horie, K Obika, A Sakamoto, S Ogawa and G Tsujimoto

Molecular Pharmacology August 1995, 48 (2) 250-258;
You have access
Characterization of phorbol ester binding to protein kinase C isotypes.
S M Dimitrijević, W J Ryves, P J Parker and F J Evans

Molecular Pharmacology August 1995, 48 (2) 259-267;
You have access
The low efficacy gamma-aminobutyric acid type A agonist 5-(4-piperidyl)isoxazol-3-ol opens brief Cl- channels in embryonic rat olfactory bulb neurons.
U Kristiansen, J L Barker and R Serafini

Molecular Pharmacology August 1995, 48 (2) 268-279;
You have access
Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
R A Houghtling, M I Dávila-García and K J Kellar

Molecular Pharmacology August 1995, 48 (2) 280-287;
You have access
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
J Priller, E M Briley, J Mansouri, W A Devane, K Mackie and C C Felder

Molecular Pharmacology August 1995, 48 (2) 288-292;
You have access
Agonist-mediated activation of phosphatidylcholine-specific phospholipase C and D in intestinal smooth muscle.
K S Murthy and G M Makhlouf

Molecular Pharmacology August 1995, 48 (2) 293-304;
You have access
Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
J L Grem, F Geoffroy, P M Politi, D P Cuddy, D D Ross, D Nguyen, S M Steinberg and C J Allegra

Molecular Pharmacology August 1995, 48 (2) 305-315;
You have access
Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
D J MacEwan, G D Kim and G Milligan

Molecular Pharmacology August 1995, 48 (2) 316-325;
You have access
Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
L L Habeck, L G Mendelsohn, C Shih, E C Taylor, P D Colman, L S Gossett, T A Leitner, R M Schultz, S L Andis and R G Moran

Molecular Pharmacology August 1995, 48 (2) 326-333;
You have access
Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase.
R S Chapman, A D Whetton, C M Chresta and C Dive

Molecular Pharmacology August 1995, 48 (2) 334-343;
You have access
Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
D H Van Leeuwen, J Eisenstein, K O'Malley and R G MacKenzie

Molecular Pharmacology August 1995, 48 (2) 344-351;
You have access
Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
D M Slipetz, G P O'Neill, L Favreau, C Dufresne, M Gallant, Y Gareau, D Guay, M Labelle and K M Metters

Molecular Pharmacology August 1995, 48 (2) 352-361;
You have access
Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
S Lazareno and N J Birdsall

Molecular Pharmacology August 1995, 48 (2) 362-378;